ARTICLE | Clinical News
Stelara ustekinumab regulatory update
June 1, 2015 7:00 AM UTC
EMA’s CHMP recommended expanding the label of Stelara ustekinumab from Johnson & Johnson’s Janssen-Cilag International N.V. unit to treat moderate to severe plaque psoriasis to include adolescent pati...